Argent BioPharma Ltd ASX:RGT:
ENTERS A GLOBAL LICENSING TRANSACTION FOR CANNEPIL WITH SPLASH BEVERAGE GROUP INC
TRANSACTION INCLUDES $5.5 MILLION UPFRONT CONSIDERATION FOR GLOBAL LICENSING RIGHTS
TO RECEIVE A 15% NET REVENUE ROYALTY ON FUTURE SBEV GLOBAL CANNEPIL REVENUES